Skip to main content

Federal Funding Opportunities

Browse federal grant opportunities from Grants.gov

Clear
HHS-NIH11 Posted
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

HHS-NIH11

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/genetic causes of cancer health dis…

Funding Range
Not specified
Total Funding
N/A
Closes: Nov 16, 2027 600 days left
View Details
HHS-NIH11 Posted
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

HHS-NIH11

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonist…

Funding Range
Not specified
Total Funding
N/A
Closes: Jan 07, 2027 287 days left
View Details
HHS-NIH11 Posted
NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)

HHS-NIH11

The NICHD Small Research Grant Program (R03Basic Experimental Studies with HumansRequired) supports clinical trials that fall within the NICHD mission and also meet the criteria for basic science exp…

Funding Range
Up to $50,000.00
Total Funding
$50,000.00
Closes: Jan 07, 2028 652 days left
View Details
HHS-NIH11 Posted
NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)

HHS-NIH11

This NIDCR Small Grant Program for New Investigators supports basic and clinical research conducted by scientists who are in the early stages of establishing an independent research career in oral, d…

Funding Range
Not specified
Total Funding
N/A
Closes: Jan 07, 2028 652 days left
View Details
HHS-NIH11 Posted
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

HHS-NIH11

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (including agonists or antagonist…

Funding Range
Not specified
Total Funding
N/A
Closes: Jan 07, 2027 287 days left
View Details
HHS-NIH11 Posted
Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)

HHS-NIH11

The purpose of this funding opportunity announcement (FOA) is to invite applications for a broad range of research efforts in computational genomics, data science, statistics, and bioinformatics rele…

Funding Range
Not specified
Total Funding
N/A
Closes: Sep 07, 2027 530 days left
View Details
HHS-NIH11 Posted
Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)

HHS-NIH11

The purpose of this notice of funding opportunity (NOFO) is to encourage community-engaged research that broadens the conceptualization of qualities of the environment that can support language devel…

Funding Range
Not specified
Total Funding
N/A
Closes: Sep 07, 2027 530 days left
View Details
HHS-NIH11 Posted
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 …

HHS-NIH11

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications proposing to conduct secondary d…

Funding Range
Up to $350,000.00
Total Funding
$350,000.00
Closes: Sep 07, 2026 165 days left
View Details
DOS-NLD Forecasted
U.S. Embassy The Hague PD Annual Program Statement

DOS-NLD

ANNUAL PROGRAM STATEMENT Funding Opportunity Title: U.S. Embassy The Hague PD Annual Program Statement Funding Opportunity Number: PD-THEHAGUE-FY25-01 Deadline for Applications: November 15, 2024 (Ad…

Funding Range
$2,000.00 – $25,000.00
Total Funding
$50,000.00
Close date: N/A
View Details
HHS-NIH11 Posted
Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)

HHS-NIH11

This Notice of Funding Opportunity (NOFO) encourages research on the biology of high-confidence risk factors associated with complex brain disorders, with a focus on the intracellular, transcellular,…

Funding Range
Not specified
Total Funding
N/A
Closes: Sep 07, 2026 165 days left
View Details
HHS-NIH11 Posted
Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

HHS-NIH11

Although the majority living with schizophrenia and related disorders are over 35 years old, including those first diagnosed and those aging with the illness, the mechanisms underlying the generation…

Funding Range
Not specified
Total Funding
N/A
Closes: Sep 07, 2026 165 days left
View Details
HHS-NIH11 Posted
Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)

HHS-NIH11

The goal of this Funding Opportunity Announcement (FOA) is to encourage applications for studies that will enhance knowledge of mechanisms associated with neuropsychiatric symptoms (NPS) in persons w…

Funding Range
Not specified
Total Funding
N/A
Closes: Sep 07, 2026 165 days left
View Details